:quality(90))
Barcelona, April 12th, 2024 – UOMi, the oncology unit of Clínicas MI, has announced a joint venture with Pratia, a leading international clinical research network with nearly a hundred research sites across Europe, to establish Pratia Sirius, a new model of clinical trials conduct, unprecedented in Spain.
Dr. Santiago Viteri, medical director of UOMi and CEO of Pratia Sirius, remarks the significance of this pioneering initiative. “Clinical trials are integral to the advancement of new oncological treatments. However, they are conducted in a fragmented manner across various hospital centers, resulting in slower and less efficient processes”. According to Dr. Viteri, “with the establishment of this autonomous unit exclusively dedicated to clinical trials, we will possess our own infrastructure and personnel, thereby expediting the research process and ensuring the quality of the outcomes”.
The initial agreement entails the opening of two centers at Clínica Mi Tres Torres in Barcelona and Clínica Mi NovAliança in Lleida. Research conducted at these facilities will focus on evaluating the efficacy and safety of novel oncological treatments, aiming to enhance patient outcomes and advancing the research against cancer.
Jaime Ballester, Country Head Pratia Spain, declares “we stay committed at Pratia to continuously increase Patients access to innovative treatments. We believe that thanks to new dedicated research units Spanish Patients will get a more comprehensive choice of therapeutic options in oncology as well as in other therapeutic areas. Dedicated site model has proven to be extremely successful in other countries. In Spain, this model adds onto our existing operations of embedded research sites and professional site staff outsourcing. We are excited of Dr. Santiago Viteri and his experienced team joining us in this new venture. Development in oncology has always been for us one of the strategic growth directions.”
This initiative sets to start in Barcelona and Lleida and aspires to establish a network of specialized clinical trials units throughout the country.
About UOMi:
UOMi is the Oncology Unit of Clínicas Mi, comprising Clínica Mi Tres Torres in Barcelona and Clínica Mi NovAliança in Lleida. It is led by oncologist Dr. Santiago Viteri. The UOMi team constitutes a highly specialized multidisciplinary unit dedicated to comprehensive care for oncology patients: from rapid and precise diagnosis to offering the most appropriate and effective treatment in each case, as well as providing personalized and attentive support to the patient and their family.
About Pratia:
Since its inception in 2014, Pratia has been dedicated to research, overseeing a network of over 90 clinical research centers and establishing a strong presence in 7 European countries. It has successfully conducted over 3.000 clinical trials, underscoring its experience and commitment to advancing medical research. With the completion of over 700 studies annually, positions Pratia as the preferred choice for a diverse range of projects. Its impact extends beyond oncology, encompassing clinical trials across a wide array of therapeutic areas, covering approximately 85% of them.
For more information:
Aleksandra Kosycarz
Pratia
+48 453 023 842 aleksandra.kosycarz@pratia.com
Paula García
Clínica MI Tres Torres
+34 93 204 13 00
pgarcia@mitrestorres.com
Eva Albiol
UOMi
+34 638 938 677
eva.albavi@gmail.com
:quality(90))